Progression from exposure |
0.27672 |
/year |
Renardy and Kirschner (2019) and Guzzetta et al. (2011)
|
Probability of active disease upon infection (child) |
0.023375 |
|
Renardy and Kirschner (2019), Guzzetta et al. (2011), and Vynnycky and Fine (1997)
|
Probability of active disease upon infection (adult) |
0.23181 |
|
Renardy and Kirschner (2019), Guzzetta et al. (2011), and Vynnycky and Fine (1997)
|
Clearance of first infections |
0.73242 |
|
Renardy and Kirschner (2019) and Guzzetta et al. (2011)
|
Protection from exogenous reinfection (child) |
0.087282 |
|
Renardy and Kirschner (2019), Guzzetta et al. (2011), and Vynnycky and Fine (1997)
|
Protection from exogenous reinfection (adult) |
0.33939 |
|
Renardy and Kirschner (2019), Guzzetta et al. (2011), and Vynnycky and Fine (1997)
|
Reactivation rate |
2.1225 × 10−4
|
/year |
Renardy and Kirschner (2019), Guzzetta et al. (2011), and Shea et al. (2014)
|
Successful treatment rate |
2.1032 |
/year |
Renardy and Kirschner (2019) and Guzzetta et al. (2011)
|
Proportion of population that is latent |
0.05 |
|
Miramontes et al. (2015) and Mancuso et al. (2016)
|